What Calmoseptine does

Calmoseptine, Inc. is a privately held U.S. pharmaceutical company headquartered in Huntington Beach, California, that manufactures and distributes a single product — Calmoseptine Ointment, a multipurpose zinc oxide-based moisture barrier ointment for skin protection, soothing, and healing. The product is indicated primarily for Incontinence-Associated Dermatitis (IAD) in children over 12 and adults with urinary and/or fecal incontinence, with a peer-reviewed clinical study (NCT02080247, published in the WCET journal) demonstrating significantly superior healing rates versus Desitin (25% vs 7.7% complete healing at day 6, p=0.009). The ointment is sold over-the-counter without prescription in multiple sizes (2.5 oz, 4.0 oz, 20g tubes, and 1/8 oz sample packets) at suggested retail prices of $5.69-$8.75 for the 4 oz tube.

The company's revenue model is single-stream OTC product sales distributed through four primary channels: major U.S. retail pharmacy chains (CVS, Walgreens, Walmart, Costco), mail-order and e-commerce platforms (Amazon, Allegro Medical, Express Medical Supply, HDIS, Walgreens online), direct company sales (minimum 1 case), and federal government procurement under Federal Supply Schedule contract No: 36F79721D0024 (valid 12-01-2020 through 11-30-2025). Internationally, distribution is handled by exclusive partners including Metro Drug Inc. in the Philippines, Zuellig Pharma in Thailand and Malaysia, and Pharmaceutical Resource Limited in Canada, with the product available across 10+ countries and brochures in 16 languages. Customer segments span individual consumers, healthcare professionals (nurses, pharmacists, physicians reached via major healthcare tradeshows), and institutional buyers (hospitals, nursing homes, long-term care facilities). The company has 11-50 employees, has held the #1 Pharmacist Recommended Brand ranking for incontinence-related skin protectants for four consecutive years from U.S. News & World Report and Pharmacy Times, and is recognized as a small business under federal contracting rules. Revenue figures are not publicly disclosed.

Name

Calmoseptine

Legal name

Calmoseptine, Inc.

Website

https://calmoseptineointment.com

Company type

Private

Founded year

1987

Operating status

Operating

Headcount range

11–50 employees

Short description

Calmoseptine, Inc. is a privately held U.S. pharmaceutical manufacturer of a single OTC zinc oxide-based multipurpose moisture barrier ointment for Incontinence-Associated Dermatitis, distributed through major U.S. retail pharmacies, mail-order, federal supply, and exclusive international partners across 10+ countries.

Ownership category

akta.pro rank

Headquarters

HQ city

Huntington Beach

HQ country

United States

HQ region

North America

Offices7 records

Markets served

GTM type

B2C

Offering type

Hardware or Manufacturing

Cost components

Operations, Supply Chain, Marketing or Sales, Personnel

Revenue model

1. Product Sales: Calmoseptine generates revenue through direct sales of its Calmoseptine Ointment product to consumers via retail pharmacies, mail order, and direct purchases from the company. The product is available without prescription at retail prices ranging from $5.69-$8.75 for consumer-sized tubes.

Pricing tiers

Go-to-market motion1 record

Distribution channels6 records

Marketing channels4 records

Core offering

Calmoseptine manufactures and sells Calmoseptine® Ointment, a multipurpose moisture barrier ointment containing zinc oxide that protects, soothes, and promotes healing of skin irritations. The product is sold over-the-counter without a prescription in 2.5 oz, 4.0 oz, and 20g tubes plus 1/8 oz sample packets, and is primarily used for the prevention and treatment of Incontinence Associated Dermatitis (IAD) in children over 12 years and adults.

Product overview

Calmoseptine is a single-product pharmaceutical company offering Calmoseptine® Ointment, a multipurpose moisture barrier ointment. The product is available over-the-counter without a prescription in multiple sizes (2.5 oz, 4.0 oz, 20g tubes, and 1/8 oz sample packets). It is manufactured in Huntington Beach, California and sold through pharmacies, major retailers (CVS, Walgreens, Walmart, Costco), and direct mail order channels.

Differentiator

Problem solved

Functional benefit

Products and services

• Calmoseptine® Ointment A zinc oxide-based multipurpose moisture barrier ointment that protects, soothes, and promotes healing of skin irritations, available over-the-counter in 2.5 oz, 4.0 oz, and 20g tubes plus 1/8 oz sample packets. Used by individuals aged 12 and older, healthcare professionals, and institutional buyers for the prevention and treatment of Incontinence Associated Dermatitis (IAD) and general skin protection.

Quantifiable outcome

• 25% of patients completely healed at day 6 with Calmoseptine vs 7.7% with Desitin (p=0.009)
• +1 more outcomes

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature1 record

Partnerships

Six partnerships are on record, tiered core and minor.

• Metro Drug Inc.coreChannel Partner/ Reseller/ DistributorExclusive distributor for Calmoseptine in the Philippines. Product available in all Mercury drug branches and most drugstores nationwide.
• Zuellig Pharma Ltd. (Thailand)coreChannel Partner/ Reseller/ DistributorAuthorized importer and distributor for Thailand. Contact: Chutima Chinhiran, Product Manager. Available in 3.5g sachets.
• Zuellig Pharma Sdn. Bhd. (Malaysia)coreChannel Partner/ Reseller/ DistributorAuthorized importer and distributor for Malaysia. Contact: Siti Nor Wana Saari, Sales/Product Manager.
• Pharmaceutical Resource Limited (Canada)coreChannel Partner/ Reseller/ DistributorCanadian distributor contact. Located at 10 Turnberry Court, St. Thomas, Ontario. Toll Free: 877-741-9295.
• American Red CrossminorOthersCalmoseptine, Inc. supports charitable causes including the American Red Cross.
• World Surgical FoundationminorOthersCalmoseptine, Inc. supports charitable causes including the World Surgical Foundation.

Scale indicators3 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Desitin (Johnson & Johnson): Johnson & Johnson's Desitin is the most direct competitor, a leading zinc oxide diaper rash paste and skin protectant explicitly benchmarked against Calmoseptine in the published WCET clinical trial — making it the closest head-to-head comparable.
• Boudreaux's Butt Paste: Boudreaux's Butt Paste is a leading OTC zinc oxide-based diaper rash and skin protectant ointment competing for the same pediatric and adult incontinence skin care shelf space at major U.S. retailers.
• Triple Paste: Triple Paste is a competitor zinc oxide-based skin protectant marketed for diaper rash and incontinence-related skin irritation, occupying the same OTC pharmacy channel and consumer use cases as Calmoseptine.
• A+D (Bayer): A+D Original Ointment is a long-standing zinc oxide and petrolatum-based skin protectant competing directly in the diaper rash and adult incontinence skin barrier category.
• Aquaphor (Beiersdorf): Aquaphor Healing Ointment is a Beiersdorf-owned skin protectant widely recommended by pharmacists and dermatologists for barrier protection, directly competing for shelf space and consumer skin protectant dollars.
• Balmex (Emerson Healthcare): Balmex is an OTC zinc oxide-based diaper rash and skin protectant cream with multi-decade heritage competing in the same OTC incontinence and diaper rash use cases as Calmoseptine.
• Medline Remedy (Medline Industries): Medline's Remedy skincare line includes moisture barrier ointments sold primarily into hospitals, long-term care, and home health — directly competing for the same institutional channel as Calmoseptine.

Broad incumbents

• Coloplast: Coloplast is a global continence care leader offering skin barriers, barrier creams, and related products through its ostomy and continence franchises — a much larger incumbent competing for both consumer and institutional incontinence skin care spend.
• ConvaTec: ConvaTec is a diversified wound and skin care company offering barrier products, ostomy accessories, and incontinence skin care — competing for institutional formularies and overlapping use cases with Calmoseptine.
• Smith & Nephew: Smith & Nephew's Advanced Wound Management portfolio includes skin protectants and barrier products sold into hospitals and long-term care — competing for the same institutional skin protectant budget as Calmoseptine.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Calmoseptine